<?xml version="1.0" encoding="UTF-8"?>
<p>Although COVID-19 is an emerging, rapidly evolving situation, clinical studies carried out in the last 5 months have revealed a great deal about its clinical manifestations and sequalae. The main symptoms of coronavirus (COVID-19) are fever, fatigue, continuous cough, and expectoration (sputum production) (
 <xref rid="B5" ref-type="bibr">5</xref>). The disease affects both lungs and most patients exhibit lymphopenia, increased levels of C-reactive protein (CRP), and elevated erythrocyte sedimentation rate (ESR) (
 <xref rid="B5" ref-type="bibr">5</xref>). The main clinical complications for COVID-19 patients are acute respiratory distress syndrome (ARDS) (
 <xref rid="B6" ref-type="bibr">6</xref>), which is associated with the “cytokine storm” syndrome, the uncontrolled production of pro-inflammatory mediators that contribute to ARDS (
 <xref rid="B7" ref-type="bibr">7</xref>).
</p>
